Abstract
the group with noted ventilation defects had a lower FEV1 (55%) than the group with no noted defects (68%) (p Z 0.07). Conclusions: Validation of 4DCT ventilation maps with clinically relevant metrics is essential. Our data demonstrate good agreement between PFTs and ventilation data, indicating that 4DCT ventilation can reliably demonstrate oncologic-based obstructive lung disease. The 4DCT-ventilation imaging enables exciting opportunities to assess pre-treatment lung function and create functional avoidance radiation therapy plans using the patient’s simulation data. The current work presents an important step for the integration of 4DCT-ventilation into clinical practice. Author Disclosure: Y. Vinogradskiy: None. L. Schubert: None. D. Brennan: None. R. Castillo: E. Research Grant; NIH. E. Castillo: E. Research Grant; NIH. T. Guerrero: E. Research Grant; NIH. M. Miften: None. B. Kavanagh: None. M.K. Mary: None.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
